Select Page

The Infinium Global Research analyzes the Transfection Reagents and Equipment Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global transfection reagents and equipment market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of transfection reagents and equipment. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the transfection reagents and equipment market during the period.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/954

Transfection is a technique that is used to introduce genetic material such as DNA or RNA, into cells. The Transfection reagents and equipment are used in this process of gene delivery. This introduction of genetic material into the preferred cells can be delivered by using various chemical, biological, or physical methods. This transfection technology helps the cells in the transformation of cancer cells, protein metabolism by affecting the nuclear genes and regulation of gene therapy.

Technological Advancements in the Transfection Methods, Increasing Synthetic Gene Demand, and Rising Incidences of Chronic Cases are Driving the Growth of the Market

The factors such as technological advancements in the transfection methods, increasing synthetic gene demand, and rising incidences of chronic cases are driving the growth of the market. Additionally, growing obese population and government initiatives to support the healthcare sector is also driving the growth of the market. However, the high cost of transfection reagents, cytotoxicity in transfection, and risk factors while insertion of the reagents is restraining the market growth. The increasing demand for synthetic genes is anticipated to provide growth opportunities to the market.

Transfection Reagents and Equipment Market: Segmentation

The transfection reagents and equipment market are segmented on the basis of product, method, application, and end user. The product segments include equipment and reagents. The reagent segment holds a large market share due to increasing commercial adoption rates of reagents. On the basis of method, the global transfection reagents and equipment market is categorized into viral methods, physical and biochemical methods. The physical segment is further Subdivided into biolistic technology, electroporation, laserfection, microinjection, nucleofection/partical bombardment, and other methods.

Biochemical Segment is further sub-categorized into calcium phosphate, catonic polymers, deae-dextran, dendrimers, lipofection/liposomes, magnetic beads. The viral segment is further sub-segmented into Adenoassociated Viruses (AAV), Adenoviruses and Retroviruses. Furthermore, on the basis of application the transfection reagents and equipment market is segmented as therapeutic delivery, protein production, and biomedical research. Based on end user, the transfection reagents and equipment market are segmented as pharmaceutical & biotechnology companies and academics & research institutes.

North America Holds a Large Market Share of the Transfection Reagents and Equipment Market

Among the geographic regions, North America holds a large market share of the transfection reagents and equipment market. The increasing incidences of various cancers and rising demand for proteomics and genomics technology drive the market growth in this region. Asia-Pacific is the fastest growing region due to the development of transfection technology in this region.

Transfection Reagents and Equipment Market: Competitive Analysis

Some of the industry participants of the global transfection reagents and equipment market are Mirus Bio LLC., Polyplus-Transfection SA, Sigma-Aldrich Corporation, Lonza Group Ltd., Maxcyte, Inc., Bio–Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Promega Corporation, and Thermo Fisher Scientific Inc. among the others.

Browse Detailed TOC and Description of this Exclusive Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-transfection-reagents-and-equipment-market

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of transfection reagents and equipment.

=> Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2023.

=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.